Ebos maintains earnings growth in uncertain environment

Ebos maintains earnings growth in uncertain environment
Ebos lost its Chemist Warehouse supply contract this year. (Image: Getty)
Staff reporters
Ebos Group maintained sales and earnings growth in the September quarter as the healthcare and animal care products maker prepares for its Chemist Warehouse supply deal to wind up next year. In speech notes published ahead of this afternoon’s annual meeting in Auckland, chief executive John Cullity said the company recorded high single-digit underlying earnings growth compared to the prior period. Stripping out the Chemist Warehouse Australia contract and covid-19 antiviral wholesale sales, underlying earnings were up 9-10% from...